Literature DB >> 21420315

Growth hormone and physical performance.

Vita Birzniece1, Anne E Nelson, Ken K Y Ho.   

Abstract

There has been limited research and evidence that GH enhances physical performance in healthy adults or in trained athletes. Even so, human growth hormone (GH) is widely abused by athletes. In healthy adults, GH increases lean body mass, although it is possible that fluid retention contributes to this effect. The most recent data indicate that GH does not enhance muscle strength, power, or aerobic exercise capacity, but improves anaerobic exercise capacity. In fact, there are adverse effects of long-term GH excess such that sustained abuse of GH can lead to a state mimicking acromegaly, a condition with increased morbidity and mortality. This review will examine GH effects on body composition and physical performance in health and disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420315     DOI: 10.1016/j.tem.2011.02.005

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  19 in total

Review 1.  Idiopathic adult growth hormone deficiency.

Authors:  Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

Review 2.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

3.  Availability and quality of illegitimate somatropin products obtained from the Internet.

Authors:  Róbert György Vida; András Fittler; Ivett Mikulka; Eszter Ábrahám; Viktor Sándor; Ferenc Kilár; Lajos Botz
Journal:  Int J Clin Pharm       Date:  2016-11-25

4.  Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner.

Authors:  Manuel D Gahete; José Córdoba-Chacón; Chike V Anadumaka; Qing Lin; Jens C Brüning; C Ronald Kahn; Raúl M Luque; Rhonda D Kineman
Journal:  Endocrinology       Date:  2011-10-11       Impact factor: 4.736

5.  GH responses to two consecutive bouts of respiratory muscle endurance training in healthy adults.

Authors:  A Sartorio; F Agosti; A Patrizi; G Tringali; N Marazzi; M Giunta; E E Muller; A E Rigamonti
Journal:  J Endocrinol Invest       Date:  2012-07-24       Impact factor: 4.256

6.  Elevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed mice.

Authors:  Manuel D Gahete; José Córdoba-Chacón; Daniel D Lantvit; Rosa Ortega-Salas; Rafael Sanchez-Sanchez; Francisco Pérez-Jiménez; José López-Miranda; Steven M Swanson; Justo P Castaño; Raúl M Luque; Rhonda D Kineman
Journal:  Carcinogenesis       Date:  2014-08-01       Impact factor: 4.944

Review 7.  Emerging options in growth hormone therapy: an update.

Authors:  Stephen F Kemp; J Paul Frindik
Journal:  Drug Des Devel Ther       Date:  2011-08-30       Impact factor: 4.162

8.  Effects of Growth Hormone Administration on Muscle Strength in Men over 50 Years Old.

Authors:  A B W Tavares; E Micmacher; S Biesek; R Assumpção; R Redorat; U Veloso; M Vaisman; P T V Farinatti; F Conceição
Journal:  Int J Endocrinol       Date:  2013-12-08       Impact factor: 3.257

9.  Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells.

Authors:  Silja Raschke; Kristin Eckardt; Kirsten Bjørklund Holven; Jørgen Jensen; Jürgen Eckel
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

10.  Performance enhancement, elite athletes and anti doping governance: comparing human guinea pigs in pharmaceutical research and professional sports.

Authors:  Silvia Camporesi; Michael J McNamee
Journal:  Philos Ethics Humanit Med       Date:  2014-02-05       Impact factor: 2.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.